EUVIMEDEUVIMED entdecken
Crossref

AI-Driven Discovery of Highly Specific and Efficacious hCES2A Inhibitors for Ameliorating Irinotecan-Triggered Gut Toxicity

Zhipei Sang, Ya Zhang, Yufan Fan, Changhai Luan, Zhengwei Liu, Qiyao Zhang, Hairong Zeng, Yunqing Song, Shuheng Huang, Guangbo Ge iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.4c02560 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Zhipei Sang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tropical Biological Resources of Ministry of Education and One Health Institute, School of Pharmaceutical Sciences, Hainan Universi…. Hauptthemen laut MEDLINE: Irinotecan, Carboxylesterase. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Natural Science Foundation of Hainan Province, Hainan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The anticancer agent irinotecan often induces severe delayed-onset diarrhea, inhibiting human carboxylesterase 2A (hCES2A) can significantly alleviate irinotecan-triggered gut toxicity (ITGT). This work presents an efficient workflow for de novo design and developing novel efficacious hCES2A inhibitors. A well-training machine learning model identified scaffold-14 as a lead compound, while compound 14n was developed as a novel time-dependent hCES2A inhibitor (IC50 = 0.04 nM) following three rounds of structural optimization. The covalent binding modes and inactivation mechanisms of 14n were elucidated by nanoLC-MS/MS-based chemoproteomics and covalent docking simulations. Notably, 14n showed excellent selectivity, good cell-membrane permeability, favorable drug-like properties, and potent inhibition on intracellular hCES2A. In vivo tests demonstrated that 14n was orally active, showing favorable safety profiles and impressive ameliorative effects on ITGT in tumor-bearing mice. Collectively, this work showcases a high-efficient AI-driven strategy for developing novel efficacious hCES2A inhibitors, while 14n emerges as a promising candidate for alleviating ITGT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IrinotecanCarboxylesteraseHumansAnimalsMiceEnzyme InhibitorsMolecular Docking SimulationDrug DiscoveryStructure-Activity RelationshipMice, Inbred BALB CAntineoplastic Agents

Substanzen

IrinotecanCarboxylesteraseCES2 protein, humanEnzyme InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Key Laboratory of Tropical Biological Resources of Ministry of Education and One Health Institute, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China.
  • State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine; Shanghai Frontiers Science Center of TCM Chemical Biology; Institute of Interdisciplinary Integrative Medicine…
  • Department of Pharmacy, Jingan District Zhabei Central Hospital, Shanghai 200070, China.
  • College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, China.

ORCID-Profile: Guangbo Ge

Förderung

  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Hainan Province
  • Hainan University
  • Shanghai University of Traditional Chinese Medicine
  • Shanghai Municipal Health Commission
  • National Natural Science Foundation of China

Zitieren

APA

Sang, Z., Zhang, Y., Fan, Y., Luan, C., Liu, Z., Zhang, Q., Zeng, H., Song, Y., Huang, S., & Ge, G. (2025). AI-Driven Discovery of Highly Specific and Efficacious hCES2A Inhibitors for Ameliorating Irinotecan-Triggered Gut Toxicity. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02560

Vancouver

Sang Z, Zhang Y, Fan Y, Luan C, Liu Z, Zhang Q, et al. AI-Driven Discovery of Highly Specific and Efficacious hCES2A Inhibitors for Ameliorating Irinotecan-Triggered Gut Toxicity. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c02560

BibTeX
@article{Sang2025,
  author = {Sang, Zhipei and Zhang, Ya and Fan, Yufan and Luan, Changhai and Liu, Zhengwei and Zhang, Qiyao and Zeng, Hairong and Song, Yunqing and Huang, Shuheng and Ge, Guangbo},
  title = {AI-Driven Discovery of Highly Specific and Efficacious hCES2A Inhibitors for Ameliorating Irinotecan-Triggered Gut Toxicity},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.4c02560}
}
Kostenlos starten →